Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy

E-resources

PDF

Full text

Peer reviewed Open access

Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy

Verdura, Sara; Cuyàs, Elisabet; Martin-Castillo, Begoña; Menendez, Javier A.

Oncoimmunology, 10/2019, Volume: 8, Issue: 10

Journal Article

The development of a single immuno-metabolic adjuvant capable of modulating, in the appropriate direction and intensity, the complex antagonistic and symbiotic interplays between tumor cells, immune cells, and the gut microbiota may appear pharmacologically implausible. Metformin might help solve this conundrum and beneficially impact the state of cancer-immune system interactions.

Keep searching

Author

Verdura, Sara | Cuyàs, Elisabet | Martin-Castillo, Begoña | Menendez, Javier A.

Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.

Year	Impact factor		Edition		Category		Classification
Year	JCR	SNIP	JCR	SNIP	JCR	SNIP	JCR	SNIP

Links to authors' personal bibliographies	Links to information on researchers in the SICRIS system

Source: Personal bibliographies and: SICRIS

Upload image

Shelf entry

Adding material to shelf was successful.

Adding material to shelf failed.

It was not necessary to add the material to the shelf.

Permalink

E-mail

Impact factor

Select the library membership card:

DRS, in which the journal is indexed

Citations

Theme